These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 4285520)
1. Antiamebic studies on 5-chloro-793-diethylaminopropyl-aminomethyl)-8-quinolinol in vitro and in experimentally infected animals. Thompson PE; Bayles A; McClay P; Meisenhelder JE J Parasitol; 1965 Oct; 51(5):817-22. PubMed ID: 4285520 [No Abstract] [Full Text] [Related]
2. Bisamidines of 2,6-diaminoanthraquinone as antiamebic agents. Fabio PF; Fields TL; Lin Y; Burden EJ; Carvajal S; Murdock KC; Lang SA J Med Chem; 1978 Mar; 21(3):273-6. PubMed ID: 203694 [TBL] [Abstract][Full Text] [Related]
3. Antiamebic action of 5-chloro-7-diethylaminomethyl-8-quinolinol and of other substituted 8-quinolinols in vitro and in experimental animals. THOMPSON PE; REINERTSON JW; BAYLES A; McCARTHY DA; ELSLAGER EF Am J Trop Med Hyg; 1955 Mar; 4(2):224-48. PubMed ID: 14361901 [No Abstract] [Full Text] [Related]
4. Progress in amebiasis. Sepulveda B Scand J Gastroenterol Suppl; 1982; 77():153-64. PubMed ID: 6289484 [No Abstract] [Full Text] [Related]
5. The amoebicidal activity and toxicity of natural emetine, (plus or minus)-2-dehydroemetine and (--)-2-dehydroemetine. Johnson P; Neal RA Ann Trop Med Parasitol; 1968 Dec; 62(4):455-61. PubMed ID: 4306633 [No Abstract] [Full Text] [Related]
6. Laboratory evaluation of panidazole (1-(2'-( -pyridyl) ethyl-2-methyl)-5-nitroimidazole), a new amoebicide. Shapero M; Jefferies HS; Ryan DM Ann Trop Med Parasitol; 1972 Jun; 66(2):187-92. PubMed ID: 4338871 [No Abstract] [Full Text] [Related]
7. Antiamoebic activity of chonemorphine, a steroidal alkaloid, in experimental models. Chatterjee DK; Iyer N; Ganguli BN Parasitol Res; 1987; 74(1):30-3. PubMed ID: 2894025 [TBL] [Abstract][Full Text] [Related]
8. [Present status of the diagnosis and treatment of invasive amebiasis caused by Entamoeba histolytica. III. Medical treatment of amebiasis]. Perches A Arch Invest Med (Mex); 1978; 9 Suppl 1():407-10. PubMed ID: 697487 [No Abstract] [Full Text] [Related]
10. Latest developments in the treatment of amebiasis. Powell SJ Adv Pharmacol Chemother; 1972; 10():91-103. PubMed ID: 4364760 [No Abstract] [Full Text] [Related]
11. Drug therapy of amoebiasis. Powell SJ Bull World Health Organ; 1969; 40(6):953-6. PubMed ID: 4310726 [No Abstract] [Full Text] [Related]
12. A new drug (MK-910) in the therapy of intestinal and hepatic amebiasis. First results of clinical trial. Chari MV; Gadiyar BN Am J Trop Med Hyg; 1970 Nov; 19(6):926-8. PubMed ID: 4321790 [No Abstract] [Full Text] [Related]
13. Efficacy and safety of paromomycin for treating amebiasis in Japan. Kikuchi T; Koga M; Shimizu S; Miura T; Maruyama H; Kimura M Parasitol Int; 2013 Dec; 62(6):497-501. PubMed ID: 23850836 [TBL] [Abstract][Full Text] [Related]
14. Therapy of amebiasis. Powell SJ Bull N Y Acad Med; 1971 May; 47(5):469-77. PubMed ID: 4929005 [No Abstract] [Full Text] [Related]
15. Pharmacology of antiamebic drugs. Thompson PE Arch Invest Med (Mex); 1970; 1():Suppl:165-72. PubMed ID: 5524343 [No Abstract] [Full Text] [Related]
16. [Treatment of amebiasis in adults]. Siguier F; Godeau P; Herreman G; Delluc G; Imbert JC Cah Coll Med Hop Paris; 1967 Dec; 8(14):1219-26. PubMed ID: 5622186 [No Abstract] [Full Text] [Related]
17. Further studies on the in vitro activity of gossypol as antiamebic agent. González-Garza MT; Matlin SA; Mata-Cárdenas BD; Said-Fernández S Arch Med Res; 1992; 23(2):69-70. PubMed ID: 1340324 [TBL] [Abstract][Full Text] [Related]
18. [Clinical problems of amebiasis]. Stahel P; Pedrinis E; Halter F; Aeberhard P Schweiz Med Wochenschr; 1975 May; 105(22):709-14. PubMed ID: 168636 [TBL] [Abstract][Full Text] [Related]